PCRX

Pacira BioSciences, Inc. Common Stock

36.43

USD

+0.01

+0.03%

Nov 06, 15:59 UTC -5

Closed

After-Market

36.43

0.00

0.00%

Pacira BioSciences, Inc. Common Stock (PCRX) Profile

Pacira BioSciences, Inc. Common Stock Profile

About

Pacira BioSciences Inc. delivers non-opioid pain therapies to transform the lives of patients. The company's commercial stage non-opioid treatments EXPAREL(R) a long-acting local analgesic for post-surgical pain management and ZILRETTA(R) an extended-release, intra-articular injection indicated for the management of osteoarthritis knee pain. Pacira BioSciences Inc., formerly known as PACIRA PHARMACT, is based in PITTSBURGH, Calif.

Info & Links

CEO

Frank D. Lee

Headquarters

2000 SIERRA POINT PARKWAY, SUITE 900
BRISBANE, CA 94005, UNITED STATES

Auditor

KPMG LLP

Share holders

Employees

829

Pacira BioSciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

1.45B

Enterprise Value

1.50B

Enterprise Value/EBITDA(ttm)

12.83

Price to Earnings Ratio(ttm)

23.35

Price to Sales(ttm)

1.95

Price to Book(mrq)

2.13

Price to Cash(ytd)

9.44

Profitability

Gross Margin(ttm)

78.74%

Operating Margin(ttm)

8.91%

Profit Margin(ttm)

5.26%

Return on Equity(ttm)

9.68%

Return on Invested Capital(ttm)

3.72%

Return on Assets(ttm)

5.30%

Income Statement

Revenue(ttm)

743.30M

Revenue Per Share(ttm)

18.54

Gross Profit(ttm)

585.19M

EBITDA(ttm)³

117.00M

Net Income Available to Common(ttm)

37.73M

Diluted EPS(ttm)

0.35

Share Statistics

Beta (5Y Monthly)

0.21

52-Week Change

65.22%

S&P 500 52-Week Change

14.38%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

40.09M

Dividend Yield

0.00%

Float⁴

37.31M

% Held by Insiders

6.40%

% Held by Institutions

99.73%

Balance Sheet

Total Cash(mrq)

295.58M

Total Cash Per Share(mrq)

7.37

Total Debt(mrq)

293.59M

Total Debt/Equity(mrq)

41.22%

Current Ratio(mrq)

4.68%

Quick Ratio(mrq)

3.94%

Book Value Per Share(mrq)

17.85

Cash Flow

Operating Cash Flow Per Share(ytd)

3.26

Free Cash Flow(ytd)

125.53M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.